Incyte Stock Breaks 7-Month Range, Analyst Sees Potential Surge

Shares of biopharmaceutical company Incyte are breaking out of a price range they have held for seven months. According to market analyst Carter Worth, this move could signal a significant upward trend for the stock. The breakout suggests that investor interest is increasing, though the company's specific catalysts remain under review.